Brightpoint Inc.

Jefferies is upgrading its rating on Brightpoint Inc. (NASDAQ: CELL) from Hold to Buy in light of the company's current valuation. According to Jefferies, “Our upgrade from Hold to Buy is due to valuation (trading at 7x our 2011 EPS estimate) and our checks that indicate handset demand has...

Jefferies & Company has maintained its Hold rating on Brightpoint Inc. (CELL). Jefferies reports,"We expected strong revenues but margin pressures. The Touchstone acq and a mix shift from EMEA to Asia pushed GM lower but ASPs higher for both Logistics and Distribution. Overall, results and...

Citigroup has downgraded Brightpoint (NASDAQ: CELL) from Buy to Hold and has lowered the price target from $17.50 to $11.

Jefferies downgrades Brightpoint (NASDAQ: CELL) from a Buy to a Hold rating